Efficacy and Safety of Combined Autologous Blood and Minocycline Pleurodesis for Intractable Pneumothorax in High‐Risk Non‐Surgical Patients: A Case Series
Abstract
Pneumothorax in patients with interstitial lung disease (ILD), severe COPD, or other significant comorbidities poses a serious therapeutic challenge, especially when surgery is contraindicated. We report a case series of 22 high‐risk patients with intractable secondary spontaneous pneumothorax (SSP) managed with combined autologous blood and minocycline pleurodesis. This bedside, sequential and non‐mixed protocol terminated persistent air leak without major complications or recurrence during a 6‐month follow‐up. Our findings suggest that this simple and accessible approach may serve as a valuable non‐surgical alternative in medically inoperable patients.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.